RANI vs. HOWL
RANI (Rani Therapeutics Holdings, Inc.) and HOWL (Werewolf Therapeutics, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 5 years, RANI returned -41.19%/yr vs -54.15%/yr for HOWL. Their 0.17 correlation means their historical movements had little consistent relationship.
Performance
RANI vs. HOWL - Performance Comparison
Loading charts...
Returns By Period
The year-to-date returns for both stocks are quite close, with RANI having a -42.66% return and HOWL slightly lower at -44.26%.
RANI
- 1D
- -5.63%
- 1M
- 0.36%
- 6M
- -36.02%
- YTD
- -42.66%
- 1Y
- 46.50%
- 3Y*
- -43.62%
- 5Y*
- -41.19%
- 10Y*
- —
- ALL TIME*
- -41.45%
HOWL
- 1D
- -29.44%
- 1M
- 3.73%
- 6M
- -46.63%
- YTD
- -44.26%
- 1Y
- -69.56%
- 3Y*
- -49.49%
- 5Y*
- -54.15%
- 10Y*
- —
- ALL TIME*
- -52.80%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $387.08K | $332.08K | $333.95K | |
| $1.10M | $840.29K | $851.46K |
RANI vs. HOWL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
RANI Rani Therapeutics Holdings, Inc. | -42.66% | -1.46% | -58.73% | -43.73% | -63.91% | 45.20% |
HOWL Werewolf Therapeutics, Inc. | -44.26% | -57.20% | -61.66% | 88.29% | -82.79% | -32.60% |
Correlation
The correlation between RANI and HOWL is 0.25, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.25 |
Correlation (3Y) Balances recent behavior with more history. | 0.20 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.17 |
Correlation (All Time) Calculated using the full available price history since Jul 30, 2021 | 0.17 |
Fundamentals
RANI:
$50.56M
HOWL:
$17.16M
RANI:
-$0.24
HOWL:
-$0.73
RANI:
64.22
HOWL:
0.80
RANI:
4.91
HOWL:
1.05
RANI:
$1.46M
HOWL:
$21.00M
RANI:
$1.05M
HOWL:
-$398.00K
RANI:
-$34.21M
HOWL:
-$25.85M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RANI vs. HOWL — Risk / Return Rank
RANI
HOWL
RANI vs. HOWL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Rani Therapeutics Holdings, Inc. (RANI) and Werewolf Therapeutics, Inc. (HOWL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| RANI | HOWL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.85 | ||
| Sortino ratioReturn per unit of downside risk | +4.26 | ||
| Omega ratioGain probability vs. loss probability | 1.39 | 0.89 | +0.50 |
| Calmar ratioReturn relative to maximum drawdown | 0.57 | -0.83 | +1.40 |
| Martin ratioReturn relative to average drawdown | 0.84 | -1.17 | +2.02 |
Loading charts...
Drawdowns
RANI vs. HOWL - Drawdown Comparison
The maximum RANI drawdown since its inception was -98.83%, roughly equal to the maximum HOWL drawdown of -98.48%. Use the drawdown chart below to compare losses from any high point for RANI and HOWL.
Loading charts...
Drawdown Indicators
| RANI | HOWL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.83% | -98.48% | -0.35% |
Max Drawdown (1Y)Largest decline over 1 year | -77.80% | -85.94% | +8.14% |
Max Drawdown (3Y)Largest decline over 3 years | -94.78% | -96.11% | +1.33% |
Max Drawdown (5Y)Largest decline over 5 years | -98.83% | -98.36% | -0.47% |
Current DrawdownCurrent decline from peak | -97.79% | -98.26% | +0.47% |
Average DrawdownAverage peak-to-trough decline | -81.02% | -77.72% | -3.30% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 52.78% | 60.39% | -7.61% |
Volatility
RANI vs. HOWL - Volatility Comparison
The current volatility for Rani Therapeutics Holdings, Inc. (RANI) is 32.88%, while Werewolf Therapeutics, Inc. (HOWL) has a volatility of 47.54%. This indicates that RANI experiences smaller price fluctuations and is considered to be less risky than HOWL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RANI | HOWL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 32.88% | 47.54% | -14.66% |
Volatility (6M)Calculated over the trailing 6-month period | 67.30% | 76.27% | -8.97% |
Volatility (1Y)Calculated over the trailing 1-year period | 273.09% | 103.93% | +169.16% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 154.43% | 103.71% | +50.72% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 154.37% | 103.22% | +51.15% |
Dividends
RANI vs. HOWL - Dividend Comparison
Neither RANI nor HOWL has paid dividends to shareholders.
Financials
RANI vs. HOWL - Financials Comparison
This section allows you to compare key financial metrics between Rani Therapeutics Holdings, Inc. and Werewolf Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
RANI and HOWL have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
HOWL has higher volatility (47.54%) compared to RANI (32.88%). In terms of maximum drawdown, RANI dropped -98.83% vs HOWL's -98.48%.
RANI currently has the higher Sharpe Ratio (0.16 vs -0.68), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for RANI and HOWL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer